Revi is the first iTNM device for the treatment of UUI labeled for use without prior failure of more conservative therapies, including medication. With concerns 3 about the potential link between ...
BlueWind Medical, Ltd., a leader in implantable Tibial NeuroModulation (iTNM) and developer of the Revi ® System, a patient-centric solution for urgency urinary incontinence (UUI), announced today the ...
The Revi® System can be used without prior failure of more conservative treatment options for urgency urinary incontinence. The US Food and Drug Administration (FDA) has granted 510(k) clearance for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results